Monday, May 5, 2014

Implementing Pharmaceutical Serialization and Traceability Perspectives and Investments - The Pew Charitable Trusts

Updated November 29, 2019

You might also be interested in:
Drug Supply Chain Security Act Law and Policies - FDA.org

- - -  the original post follows below  - - -

Implementing Pharmaceutical Serialization and Traceability Perspectives and Investments: - The Pew Charitable Trusts

"The Pew Charitable Trusts’ drug safety project and Booz Allen Hamilton conducted a qualitative assessment in 2013 of stakeholder perspectives on serialization and traceability systems across the U.S. pharmaceutical distribution supply chain. The analysis in the report Implementing a Pharmaceutical Serialization and Traceability System in the United States: Stakeholder Perspectives and Investments offers a high-level snapshot of industry expectations, system preferences, and anticipated investments that can inform implementation of DQSA. "

'via Blog this'

Read The Report:  Implementing a Pharmaceutical Serialization and Traceability System in the United States: Stakeholder Perspectives and Investments (PDF)

Return Home:  The Designated Representative and Exemptee Blog

-------------

The largest selection of Board-approved California Designated Representative online training classes for wholesalers, 3PL, reverse distributors. Earns a training affidavit.
The largest selection of Board-approved California Designated Representative online training classes for wholesalers, 3PL, reverse distributors. Earns a training affidavit.



For Designated Representative license applicants  -  Training programs, courses, classes, seminars:

     California (earn a training affidavit):
     Florida:

For HMDR Exemptee license applicants  -  Training programs, courses, classes, seminars:

     California (earn a training completion certificate):

Custom Search

From SkillsPlus International Inc.